Extracorporeal Photopheresis (ECP) is a cutting-edge immunomodulatory therapy that selectively targets and reprograms white blood cells to normalize immune function—without causing systemic immunosuppression. This extracorporeal treatment is effective in managing graft-versus-host disease (GVHD), certain cancers, transplant rejection, autoimmune, and inflammatory disorders.

At GS Medical Services, we partner with elite integrative medicine clinics equipped with advanced ECP systems to deliver safe, personalized therapies backed by medical evidence.

How ECP Works

1. Leukapheresis: Patient’s blood is drawn and white blood cells are separated.

2. Photoactivation: Cells are treated with a photosensitizer (e.g., methoxsalen or 8-MOP) and exposed to UVA light, causing selective apoptosis.

3. Reinfusion: Treated cells are infused back, modulating immune response via regulatory T‑cell activation and anti-inflammatory cytokine release.

Typically, ECP is performed over 2–4 hours per session, with cycles scheduled based on patient response—usually weekly or bi-weekly at first.

Clinical Indications

ECP is approved or used off-label for a wide range of medical conditions:

• Cutaneous T‑cell lymphoma (CTCL: Sézary syndrome, mycosis fungoides) – first-line therapy.

• Graft‑versus‑host disease (GVHD), both acute and chronic, especially steroid-refractory cases.

• Organ transplant rejection (heart, lung, liver, kidney).

• Autoimmune and inflammatory disorders: systemic sclerosis, lupus, Crohn’s disease, psoriasis, atopic dermatitis, pemphigus, type 1 diabetes, and nephrogenic fibrosing dermopathy.

Emerging evidence indicates its utility in ALS, MS, and idiopathic pulmonary fibrosis.

Benefits of ECP

• Immune modulation without global suppression—preserves normal immune defense.

• Safe, well-tolerated with minimal side effects such as mild hypotension, dizziness, or skin photosensitivity.

• Steroid-sparing therapy, reducing long-term drug side effects.

• Clinically proven: CTCL responses in ~43% of patients (complete ~10%), GVHD response up to 80% for skin-limited disease.

ECP has shown no increased risk of infection, cancer recurrence, or other serious complications over decades.

Safety & Procedure

• Procedure is non-surgical, with patients typically reclining comfortably.

• Side effects are mild and transient: dizziness, fatigue, nausea, IV-site bruising.

• Patients must avoid direct or indirect UV exposure for 24 hours post-treatment and may need sunscreen or protective eyewear.

Why Choose GS Medical Services for ECP?

• Global network of leading integrative and regenerative clinics in Switzerland, Germany, Austria, UAE, India, and beyond

• Access to state-of-the-art ECP equipment, including closed systems reducing infection risk

• Evidence-based protocols, holistic diagnostic workups, and long-term follow-up

• Seamless care coordination—from initial consultation to travel, treatment, and aftercare

• Personalized plans designed by internationally accredited immunology and transplant experts

Explore Leading Clinics & Doctors for ECP

Below, you’ll find a curated list of world-renowned clinics and physicians specializing in extracorporeal photopheresis. Each partner is selected by GS Medical Services based on clinical outcomes, technical expertise, and commitment to personalized, holistic care.

Browse the list to find the best fit for your needs or contact our medical concierge team—we’ll guide you to the right specialist and clinic based on your health profile and location.